Ads
related to: astellas pharmaceuticals careers opportunities- Jobs in North Carolina
245 Vacancies available
in your City. Don't miss any.
- Latest Jobs in Florida
Explore all available Vacancies
in your City
- Latest Jobs in New Jersey
All available Jobs listed
Find your New Job
- Jobs in Georgia
Explore the latest jobs
Check them and Apply now
- Jobs in North Carolina
Search results
Results from the WOW.Com Content Network
Astellas Pharma office in Canada. Astellas Pharma Inc. (アステラス製薬株式会社, Asuterasu Seiyaku Kabushiki-gaisha) is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. (山之内製薬株式会社, Yamanouchi Seiyaku Kabushiki-gaisha) and Fujisawa Pharmaceutical Co., Ltd. (藤沢薬品工業株式会社 ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Astellas Institute for Regenerative Medicine is a subsidiary of Astellas Pharma located in Marlborough, Massachusetts, US, developing stem cell therapies with a focus on diseases that cause blindness. It was formed in 1994 as a company named Advanced Cell Technology, Incorporated (ACT), which was renamed to Ocata Therapeutics in November 2014. [3]
Career Education Corporation (Hoffman Estates) DeVry University ; Encyclopædia Britannica, Inc. (Chicago) Follett Corporation (River Grove) Kendall College, LLC (Chicago) PrepMe (Chicago) Rand McNally , a subsidiary of Quebecor World; Replogle (Chicago) Riverside Publishing (Rolling Meadows) Tribeca Flashpoint Media Arts Academy (Chicago)
Astellas Pharma, a multinational pharmaceutical company of Japan, and part of the Mitsubishi UFJ Financial Group conglomerate. Pages in category "Astellas Pharma" The following 27 pages are in this category, out of 27 total.
OSI Pharmaceuticals, Inc. was an American pharmaceutical company formerly based in Long Island, New York with facilities in Colorado, New Jersey and the United Kingdom. On Sunday, May 16, 2010 OSI agreed to be acquired by Japan-based, TSE-listed Astellas Pharma for $4.0 billion. [4] The deal was closed on June 9, 2010.
The company also has collaboration agreements for their ADC technology with a number of biotechnology and pharmaceutical companies, including AbbVie, Bayer Celldex Therapeutics, Inc., Daiichi Sankyo, Genentech, Inc., GlaxoSmithKline, Pfizer, Inc., and PSMA Development Company LLC, as well as ADC co-development agreements with Agensys, Inc., an ...
Zolbetuximab has been tested in two phase III clinical trials for gastric cancer, SPOTLIGHT and GLOW. [11] [12] A combined analysis of the two trials confirmed that zolbetuximab, when added to chemotherapy, improved progression-free survival and overall survival for patients with HER2-negative, locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma ...
Ads
related to: astellas pharmaceuticals careers opportunities